tiprankstipranks
Trending News
More News >
AXT Inc (AXTI)
:AXTI

AXT (AXTI) AI Stock Analysis

Compare
934 Followers

Top Page

AXTI

AXT

(NASDAQ:AXTI)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
$12.50
▼(-15.60% Downside)
AXT's stock score is primarily influenced by strong technical momentum, which is offset by weak financial performance and unattractive valuation. The earnings call provided some positive insights into revenue growth and margin improvements, but ongoing challenges in profitability and cash flow management remain significant concerns.
Positive Factors
Revenue Growth
The significant revenue growth indicates strong demand and market expansion, particularly in data centers, enhancing AXT's market position.
Indium Phosphide Demand
Rising demand for indium phosphide in data centers suggests a strong market for AXT's products, supporting long-term growth potential.
Gross Margin Improvement
Improved gross margins reflect better operational efficiency and product mix, which can enhance profitability over time.
Negative Factors
Net Loss Persisting
Ongoing net losses indicate financial challenges, which could hinder investment in growth and innovation if not addressed.
Export Permit Delays
Delays in export permits can disrupt supply chains and revenue realization, affecting customer satisfaction and market competitiveness.
Germanium Substrates Decline
Declining sales in germanium substrates suggest challenges in product diversification and profitability, impacting overall business health.

AXT (AXTI) vs. SPDR S&P 500 ETF (SPY)

AXT Business Overview & Revenue Model

Company DescriptionAXT Inc. (AXTI) is a leading manufacturer of compound semiconductor substrates and related materials, primarily serving the optoelectronics, wireless communication, and solar industries. The company specializes in the production of indium phosphide (InP), gallium arsenide (GaAs), and gallium nitride (GaN) substrates, which are essential for high-performance electronic and photonic devices. AXT's products are utilized in a variety of applications, including fiber optic communications, LEDs, and solar cells, positioning the company at the forefront of technology in sectors that demand cutting-edge materials.
How the Company Makes MoneyAXT generates revenue through the sale of its compound semiconductor substrates and related products to a diverse range of customers, including manufacturers in the telecommunications, electronics, and renewable energy sectors. Key revenue streams include direct sales of substrates, as well as custom products tailored to specific customer needs. The company benefits from long-term relationships with major clients in the optoelectronic and wireless communication markets, which provide stability and predictability to its revenue. Additionally, AXT's ongoing investments in research and development allow it to innovate and expand its product offerings, creating new revenue opportunities. Strategic partnerships with technology firms and academic institutions also enhance its market reach and contribute to its financial performance.

AXT Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 19, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong revenue growth and improved margins primarily driven by increased demand for indium phosphide in data centers. However, challenges remain with ongoing net losses, export permit delays, and declines in germanium substrates. Overall, while there are positive trends, significant challenges persist.
Q3-2025 Updates
Positive Updates
Significant Revenue Growth
Revenue for Q3 2025 was $28.0 million, a 56% increase from Q2 2025 and an 18% increase year-over-year.
Indium Phosphide Demand Surge
Indium phosphide revenue reached its highest level since 2022, contributing $13.1 million, driven by data center applications.
Substantial Improvement in Operating Loss
Non-GAAP operating loss improved to $384,000 in Q3 2025 from $6.1 million in Q2 2025.
Gross Margin Improvement
Non-GAAP gross margin improved to 22.4% in Q3 2025 from 8.2% in Q2 2025.
Record Indium Phosphide Backlog
The indium phosphide order backlog has grown to more than $49 million.
Negative Updates
Net Loss Persisting
Non-GAAP net loss for Q3 2025 was $1.2 million or $0.03 per share, though improved from $6.4 million in Q2 2025.
Export Permit Delays
Export permits for indium phosphide are taking longer than expected, approximately 60 business days, impacting timely shipments.
Germanium Substrates Decline
Sales in germanium substrates declined by about $1 million in Q3 2025, with poor gross margin potential.
Decrease in Cash and Cash Equivalents
Cash and cash equivalents decreased by $3.9 million to $31.2 million as of September 30, primarily due to increased accounts receivable.
Company Guidance
During AXT's Third Quarter 2025 Financial Conference Call, the company provided detailed guidance on their financial performance and future expectations. AXT reported a revenue of $28.0 million for Q3 2025, marking a 56% sequential increase and 18% year-over-year growth. Indium phosphide revenue reached $13.1 million, the highest since 2022, driven primarily by data center and PON applications. The company's non-GAAP gross margin improved to 22.4% from 8.2% in Q2 2025, attributed to improved product mix and higher volume absorption. Despite a non-GAAP net loss of $1.2 million or $0.03 per share, this was a substantial improvement compared to a $6.4 million loss in Q2 2025. AXT's backlog for indium phosphide orders exceeded $49 million, with the company highlighting strong demand from data center expansions in the U.S. and emerging applications in AI and optical transceivers. The company anticipates Q4 2025 revenue to be between $27 million and $30 million, subject to the timing of export permits, with expectations of further gross margin improvements and a narrowed non-GAAP net loss ranging from $0.01 to $0.03 per share.

AXT Financial Statement Overview

Summary
AXT is facing significant financial challenges, particularly in profitability and cash flow management. Despite positive revenue growth, the company struggles with negative margins and returns. The balance sheet is relatively stable, but improvements in operational efficiency and profitability are crucial for long-term sustainability.
Income Statement
40
Negative
AXT's income statement reveals a challenging period with declining profitability. The TTM data shows a negative net profit margin of -25.22% and a gross profit margin of 11.97%, indicating pressure on profitability. Revenue growth is positive at 5.01% TTM, but the EBIT and EBITDA margins are negative, reflecting operational inefficiencies. The company needs to address these challenges to improve its financial health.
Balance Sheet
55
Neutral
The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.35 TTM, which is manageable. However, the return on equity is negative at -12.38% TTM, indicating that the company is not generating sufficient returns on shareholders' equity. The equity ratio is stable, suggesting a solid asset base, but the company needs to improve its profitability to enhance shareholder value.
Cash Flow
45
Neutral
Cash flow analysis indicates a challenging situation with negative operating cash flow of -$15.8 million TTM. Free cash flow growth is positive at 35.55% TTM, but the operating cash flow to net income ratio is negative, highlighting cash flow issues. The free cash flow to net income ratio is above 1, suggesting some efficiency in converting net income to free cash flow, but overall cash flow management needs improvement.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue90.39M99.36M75.80M141.12M137.39M95.36M
Gross Profit10.82M23.84M13.32M52.12M47.41M30.27M
EBITDA-13.53M-338.00K-8.78M30.12M25.10M11.63M
Net Income-22.80M-11.62M-17.88M15.81M14.57M3.24M
Balance Sheet
Total Assets334.03M339.31M358.70M370.07M332.44M298.86M
Cash, Cash Equivalents and Short-Term Investments23.11M22.83M39.89M44.29M42.18M72.84M
Total Debt63.70M49.78M55.73M48.88M16.54M13.23M
Total Liabilities93.58M84.41M89.56M80.33M52.21M43.33M
Stockholders Equity179.15M192.77M203.99M221.61M211.53M192.62M
Cash Flow
Free Cash Flow-18.93M-17.88M-7.07M-37.23M-32.95M-13.99M
Operating Cash Flow-15.80M-12.11M3.40M-8.77M-3.31M5.87M
Investing Cash Flow-4.24M-4.45M-2.60M-25.22M-38.81M-16.42M
Financing Cash Flow6.71M-536.00K8.61M38.03M5.72M52.66M

AXT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14.81
Price Trends
50DMA
8.65
Positive
100DMA
5.88
Positive
200DMA
3.79
Positive
Market Momentum
MACD
1.81
Negative
RSI
69.49
Neutral
STOCH
89.64
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AXTI, the sentiment is Positive. The current price of 14.81 is above the 20-day moving average (MA) of 11.54, above the 50-day MA of 8.65, and above the 200-day MA of 3.79, indicating a bullish trend. The MACD of 1.81 indicates Negative momentum. The RSI at 69.49 is Neutral, neither overbought nor oversold. The STOCH value of 89.64 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AXTI.

AXT Risk Analysis

AXT disclosed 58 risk factors in its most recent earnings report. AXT reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

AXT Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$341.75M24.7322.20%5.66%-9.48%-14.28%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
$690.49M-12.00%-4.54%-119.39%
54
Neutral
$209.37M-366.40-0.91%-0.41%-134.49%
51
Neutral
$162.76M-5.50-23.56%7.53%-15.00%
49
Neutral
$285.43M40.881.74%-10.74%
41
Neutral
$75.08M-3.51-116.86%-94.26%3.20%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AXTI
AXT
14.81
12.58
564.13%
NVEC
NVE
70.65
-4.53
-6.03%
ATOM
Atomera
2.37
-5.37
-69.38%
MRAM
Everspin Technologies
9.16
2.70
41.80%
VLN
Valens
1.59
-0.47
-22.82%
XPER
Xperi Inc
6.16
-4.61
-42.80%

AXT Corporate Events

AXT Inc. Earnings Call: Growth Amid Challenges
Nov 1, 2025

The recent earnings call for AXT Inc. painted a picture of mixed sentiments, with strong revenue growth and improved margins being overshadowed by persistent challenges. The company has seen an uptick in demand for indium phosphide, particularly in data centers, which has bolstered their financial performance. However, ongoing net losses, export permit delays, and declines in germanium substrates continue to pose significant hurdles. Despite these challenges, there are positive trends that indicate potential for future growth.

AXT, Inc. Reports Strong Q3 Revenue Growth
Oct 31, 2025

AXT, Inc. is a material science company specializing in the development and manufacturing of high-performance compound and single element semiconductor wafer substrates, primarily serving industries such as 5G infrastructure and data center connectivity.

Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
AXT Subsidiary Secures Export Permits in China
Positive
Aug 19, 2025

In August 2025, Beijing Tongmei Xtal Technology Co., Ltd., a subsidiary of AXT, Inc., received export permits from the Ministry of Commerce of China to resume shipping indium phosphide substrates to additional customers, following export control restrictions announced in February 2025. This development is expected to generate several million dollars in revenue not included in the company’s third-quarter forecast, potentially impacting the company’s financial performance positively.

The most recent analyst rating on (AXTI) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on AXT stock, see the AXTI Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 10, 2025